HI
ADMA icon

Harbour Investments’s ADMA Biologics ADMA Stock Holding History

Harbour Investments’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.57K Buy
1,024
+1,020
+25,500% +$9.3K ﹤0.01% 3440
2026
Q1 		$36 Hold
4
– – ﹤0.01% 4594
2025
Q4 		$73 Sell
4
-93
-96% -$1.57K ﹤0.01% 3759
2025
Q3 		$1.42K Sell
97
-35,478
-100% -$608K ﹤0.01% 3350
2025
Q2 		$648K Buy
+35,575
New +$725K 0.02% 678

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Harbour Investments's ADMA Position: Q2 2026 in Review

Harbour Investments increased its ADMA Biologics (ADMA) stake by 25,500% in Q2 2026, buying an estimated $9.3K and bringing the position to 1,024 shares worth $8.57K. The position accounts for ﹤0.01% of the portfolio, ranked #3440.

Harbour Investments first reported a position in ADMA in Q2 2025 and has held it in 5 quarters since. The position peaked at $648K in Q2 2025. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Harbour Investments held 1,024 shares of ADMA Biologics worth $8.57K as of Q2 2026.
  • Harbour Investments bought 1,020 ADMA Biologics shares in Q2 2026, an estimated $9.3K.
  • ADMA Biologics made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #3440 holding.
  • Harbour Investments first reported a position in ADMA Biologics in Q2 2025 and has held it in 5 quarters since.
  • Harbour Investments's ADMA Biologics position peaked at $648K in Q2 2025.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.